Study on urinary incontinence after curative prostatectomy for prostate cancer patients to evaluate urinary incontinence and safety using Imidafenacin twice a day

Dong-A University Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年3月4日

适应症

试验速览

•1) Patients diagnosed with prostate cancer and subjected to radical prostatectomy
•2) Not taking anticholinergic drugs before surgery
•3) After removal of the Foley catheter after surgery, at 2 to 4 weeks after surgery
•4) If the subject has signed and dated the test subject agreement confirming that the information on the overall contents of the test has been provided prior to registration
•5) You are willing and able to complete scheduled visits, treatment plans, laboratory tests, and other testing procedures

•1) Prostate-proven prostate cancer was treated with radical prostatectomy but the histology was not adenocarcinoma
•2) Neoadjuvant hormone therapy before radical prostatectomy.
•3) 60 days after radical prostatectomy
•4) Serious side effects after surgery
•5) Patients with severe gastrointestinal disorders including addictive megacolon
•6) Patients with myasthenia gravis
•7) Patients with narrow angle glaucoma
•8) Patients with severe renal disease
•Patients with severe hepatic impairment (Child class C)
•10) Patients who are hypersensitive to anticholinergic agents
•11) Patients with genetic problems such as galactose intolerance, lactose dehydrogenase deficiency or glucose-galactose uptake disorder
•12) Patients with uncontrolled diabetes
•13) Patients with QT prolongation (QTc> 500 msec) on Electrocardiogram
•14) If you are participating in other clinical trials
•15) Other severe acute or chronic medical or mental conditions or laboratory abnormalities which, when deemed by the tester, would appear to result in an excessive risk of participation in the study or administration of the test drug, or that would make it inappropriate to participate in the study

发起方